Heme oxygenase and the cardiovascular-renal system
- PMID:15925276
- DOI: 10.1016/j.freeradbiomed.2005.03.010
Heme oxygenase and the cardiovascular-renal system
Abstract
Heme oxygenase (HO) has been shown to be important for attenuating the overall production of reactive oxygen species (ROS) through its ability to degrade heme and to produce carbon monoxide (CO), biliverdin/bilirubin, and the release of free iron. Excess free heme catalyzes the formation of ROS, which may lead to endothelial cell (EC) dysfunction as seen in numerous pathological conditions including hypertension and diabetes, as well as ischemia/reperfusion injury. The upregulation of HO-1 can be achieved through the use of pharmaceutical agents, such as metalloporphyrins and some HMG-CoA reductase inhibitors. Among other agents, atrial natriretic peptide and donors of nitric oxide (NO) are important modulators of the heme-HO system, either through induction of HO-1 or the biological activity of its products. Gene therapy and gene transfer, including site- and organ-specific targeted gene transfer, have become powerful tools for studying the potential role of HO-1/HO-2 in the treatment of various cardiovascular diseases as well as diabetes. HO-1 induction by pharmacological agents or gene transfer of human HO-1 into endothelial cells (ECs) in vitro increases cell-cycle progression and attenuates Ang II, TNF-, and heme-mediated DNA damage; administration in vivo acts to correct blood pressure elevation following Ang II exposure. Moreover, site-specific delivery of HO-1 to renal structures in spontaneously hypertensive rats (SHR), specifically to the medullary thick ascending limb of the loop of Henle (mTALH), has been shown to normalize blood pressure and provide protection to the mTAL against oxidative injury. In other cardiovascular situations, delivery of human HO-1 to hyperglycemic rats significantly lowers superoxide (O(2)(-)) levels and prevents EC damage and sloughing of vascular EC into the circulation. In addition, administration of human HO-1 to rats in advance of ischemia/reperfusion injury considerably reduces tissue damage. The ability to upregulate HO-1 through pharmacological means or through the use of gene therapy may offer therapeutic strategies for cardiovascular disease in the future. This review discusses the implications of HO-1 delivery during the early stages of cardiovascular system injury or in early vascular pathology and suggests that pharmacological agents that regulate HO activity or HO-1 gene delivery itself may become powerful tools for preventing the onset or progression of certain cardiovascular pathologies.
Similar articles
- Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system.Peterson SJ, Frishman WH, Abraham NG.Peterson SJ, et al.Cardiol Rev. 2009 May-Jun;17(3):99-111. doi: 10.1097/CRD.0b013e31819d813a.Cardiol Rev. 2009.PMID:19384082Review.
- [Heme oxygenase and carbon monoxide in the physiology and pathology of the cardiovascular system].Bełtowski J, Jamroz A, Borkowska E.Bełtowski J, et al.Postepy Hig Med Dosw (Online). 2004 Mar 3;58:83-99.Postepy Hig Med Dosw (Online). 2004.PMID:15069378Review.Polish.
- Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury.Quan S, Yang L, Shnouda S, Schwartzman ML, Nasjletti A, Goodman AI, Abraham NG.Quan S, et al.Kidney Int. 2004 May;65(5):1628-39. doi: 10.1111/j.1523-1755.2004.00562.x.Kidney Int. 2004.PMID:15086901
- A significant role for the heme oxygenase-1 gene in endothelial cell cycle progression.Kushida T, Quan S, Yang L, Ikehara S, Kappas A, Abraham NG.Kushida T, et al.Biochem Biophys Res Commun. 2002 Feb 15;291(1):68-75. doi: 10.1006/bbrc.2002.6403.Biochem Biophys Res Commun. 2002.PMID:11829463
- Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes.Rodella L, Lamon BD, Rezzani R, Sangras B, Goodman AI, Falck JR, Abraham NG.Rodella L, et al.Free Radic Biol Med. 2006 Jun 15;40(12):2198-205. doi: 10.1016/j.freeradbiomed.2006.02.018. Epub 2006 Mar 20.Free Radic Biol Med. 2006.PMID:16785033
Cited by
- Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure.Collino M, Pini A, Mugelli N, Mastroianni R, Bani D, Fantozzi R, Papucci L, Fazi M, Masini E.Collino M, et al.Dis Model Mech. 2013 Jul;6(4):1012-20. doi: 10.1242/dmm.011528. Epub 2013 Apr 16.Dis Model Mech. 2013.PMID:23592614Free PMC article.
- Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression.Wright MM, Schopfer FJ, Baker PR, Vidyasagar V, Powell P, Chumley P, Iles KE, Freeman BA, Agarwal A.Wright MM, et al.Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4299-304. doi: 10.1073/pnas.0506541103. Epub 2006 Mar 6.Proc Natl Acad Sci U S A. 2006.PMID:16537525Free PMC article.
- The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus.Oates JC, Gilkeson GS.Oates JC, et al.Clin Immunol. 2006 Dec;121(3):243-50. doi: 10.1016/j.clim.2006.06.001. Epub 2006 Jul 24.Clin Immunol. 2006.PMID:16861040Free PMC article.Review.
- Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm.Meital LT, Windsor MT, Perissiou M, Schulze K, Magee R, Kuballa A, Golledge J, Bailey TG, Askew CD, Russell FD.Meital LT, et al.Sci Rep. 2019 Sep 10;9(1):12978. doi: 10.1038/s41598-019-49362-z.Sci Rep. 2019.PMID:31506475Free PMC article.
- Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, Stocker R.Wu BJ, et al.J Exp Med. 2006 Apr 17;203(4):1117-27. doi: 10.1084/jem.20052321. Epub 2006 Apr 10.J Exp Med. 2006.PMID:16606673Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous